The prognosis for infants with SCID has improved significantly with early diagnosis and advances in treatment. With timely HSCT, many children can achieve near-normal immune function and lead healthy lives. However, without appropriate treatment, SCID is almost invariably fatal within the first year of life due to overwhelming infections.
